Roche Media 9 ene 2026 Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
Roche Media 9 ene 2026 Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
FierceBiotech 9 ene 2026 Roche returns to MediLink with promise of $570M near-term payments for another ADC
Roche Media 9 ene 2026 Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
Endpoints News 8 ene 2026 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News 8 ene 2026 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
Roche Media 6 ene 2026 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech
Roche Media 6 ene 2026 Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace
Roche Media 26 dic 2025 Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
Roche Media 22 dic 2025 Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues
Roche Media 11 dic 2025 Roche hails giredestrant effect in ER-positive early-stage breast cancer - The Pharma Letter